Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAIC 2023 | Relationship between retinal and cortical tau pathology

Frederique Hart de Ruyter • 18 Jul 2023
AAIC 2023
Alzheimer’s Disease Dementia

Frederique J. Hart de Ruyter, MD, from Vrije Universiteit Amsterdam, Amsterdam UMC, Netherlands, discusses the correlation between retinal phosphorylated tau (pTau) concentration and pTau pathology found in brain tissue. Immunohistochemical analysis of pTau in the retina found a positive correlation with pTau found cortical regions of the brain, including the hippocampus, in patients with Alzheimer’s disease. Recorded at the Alzheimer’s Association International Conference (AAIC)® 2023 held in Amsterdam, Netherlands.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Frederique Hart de Ruyter

Retinal protein aggregates as biomarkers in Alzheimer’s and Parkinson’s disease.
2:06
Retinal protein aggregates as biomarkers in Alzheimer’s and Parkinson’s disease.
Frederique Hart de Ruyter • 18 Jul 2023
AI with advanced retinal imaging techniques to detect neurodegenerative disease risk markers
4:17
AI with advanced retinal imaging techniques to detect neurodegenerative disease risk markers
Frederique Hart de Ruyter • 18 Jul 2023
Retinal microglia and tau biomarkers in Alzheimer’s disease
4:14
Retinal microglia and tau biomarkers in Alzheimer’s disease
Frederique Hart de Ruyter • 18 Jul 2023

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
2:44
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
Jacqui Cannon • 5 Aug 2026
The Lewy Body Society's mission and impact
2:38
The Lewy Body Society's mission and impact
Jacqui Cannon • 5 Aug 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals